Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03207347
Title A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Florida
Indications

malignant mesothelioma

cholangiocarcinoma

renal cell carcinoma

uveal melanoma

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Florida Gainesville Florida 32610 United States Details
University of Miami Miami Florida 33136 United States Details
Orlando Health UF Health Cancer Center Orlando Florida 32806 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field